| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Vice President &CMO | Executive VP R&D, CMO | Executive Vice President R&D
1 company
Schwabe Stefan K.F. is an Executive Vice President &CMO at SUPERNUS PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $123K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2020 | SUPN Supernus Pharmaceuticals, Inc. | Executive Vice President &CMO | Sale+OE | 46,347 | $22.10 | $1,024,463.36 | -94.4% | |
| Dec 14, 2020 | SUPN Supernus Pharmaceuticals, Inc. | Executive Vice President &CMO | Sale+OE | 53,653 | $21.87 | $1,173,263.56 | -85.4% | |
| Jun 18, 2018 | SUPN Supernus Pharmaceuticals, Inc. | Executive VP R&D, CMO | Sale+OE | 60,000 | $54.39 | $3,263,352.00 | -96.8% | |
| Sep 7, 2017 | SUPN Supernus Pharmaceuticals, Inc. | Executive Vice President R&D | Sale+OE | 95,000 | $46.59 | $4,425,575.00 | -98.1% | |
| Jul 28, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Executive Vice President R&D | Sell | 2,350 | $21.20 | $49,826.50 | -58.0% | |
| Jul 13, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Executive Vice President R&D | Sell | 1,950 | $19.23 | $37,498.50 | -69.8% | |
| Jun 12, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Executive Vice President R&D | Sell | 2,051 | $18.27 | $37,471.77 | -42.3% | |
| Jun 11, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Executive Vice President R&D | Sell | 3,631 | $16.39 | $59,520.81 | -23.3% |